Answers are grounded in this paper and cite their sources.
Inhaler-related emissions in the US have increased over the past decade. Policymakers and regulators seeking to reduce emissions should identify targeted solutions aimed at shifting utilization to currently marketed dry powder and soft mist inhalers while facilitating the entry of newer, affordable metered-dose products containing propellants with low global warming potential.
No takes yet. Share an insight, caveat, or question.
Feldman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: